IL7R
Interleukin-7 receptor subunit alpha
Also known as: CD127, IL7RA, IL7RA_HUMAN, lnc-IL7R
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P16871
- Gene
- IL7R
- Ensembl
- ENSG00000168685
- Chromosome
- 5
- Canonical length
- 459 aa
- Protein class
- Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
The protein encoded by this gene is a receptor for interleukin 7 (IL7). The function of this receptor requires the interleukin 2 receptor, gamma chain (IL2RG), which is a common gamma chain shared by the receptors of various cytokines, including interleukins 2, 4, 7, 9, and 15. This protein has been shown to play a critical role in V(D)J recombination during lymphocyte development. Defects in this gene may be associated with severe combined immunodeficiency (SCID). Alternatively spliced transcript variants have been found. [provided by RefSeq, Dec 2015]
Canonical amino-acid sequenceUniProt
459 residues, UniProt reviewed canonical sequence.
>P16871|IL7R
1 MTILGTTFGM VFSLLQVVSG ESGYAQNGDL EDAELDDYSF SCYSQLEVNG SQHSLTCAFE
61 DPDVNITNLE FEICGALVEV KCLNFRKLQE IYFIETKKFL LIGKSNICVK VGEKSLTCKK
121 IDLTTIVKPE APFDLSVVYR EGANDFVVTF NTSHLQKKYV KVLMHDVAYR QEKDENKWTH
181 VNLSSTKLTL LQRKLQPAAM YEIKVRSIPD HYFKGFWSEW SPSYYFRTPE INNSSGEMDP
241 ILLTISILSF FSVALLVILA CVLWKKRIKP IVWPSLPDHK KTLEHLCKKP RKNLNVSFNP
301 ESFLDCQIHR VDDIQARDEV EGFLQDTFPQ QLEESEKQRL GGDVQSPNCP SEDVVITPES
361 FGRDSSLTCL AGNVSACDAP ILSSSRSLDC RESGKNGPHV YQDLLLSLGT TNSTLPPPFS
421 LQSGILTLNP VAQGQPILTS LGSNQEEAYV TMSSFYQNQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IL7R can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.51
- Highest tissue expression
- 171 nTPM
Expression across tissuesHPA
Tissue
- thymus: 171 nTPM
- lymph node: 131 nTPM
- appendix: 130 nTPM
- tonsil: 116 nTPM
- spleen: 66 nTPM
- lung: 60 nTPM
Single-cell type
- innate lymphoid cells: 3,240 nCPM
- t-cells: 1,496 nCPM
- thymocytes: 458 nCPM
- cdc: 228 nCPM
- nk-cells: 163 nCPM
- macrophages: 69 nCPM
Immune cell
- MAIT T-cell: 370 nTPM
- memory CD4 T-cell: 214 nTPM
- naive CD4 T-cell: 180 nTPM
- memory CD8 T-cell: 151 nTPM
- naive CD8 T-cell: 125 nTPM
- NK-cell: 113 nTPM
Brain region
- cerebellum: 32 nTPM
- white matter: 28 nTPM
- thalamus: 28 nTPM
- cerebral cortex: 22 nTPM
- hypothalamus: 22 nTPM
- pons: 20 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IL7R.
Disease | AllUniProt
Conditions IL7R is implicated in, by any mechanism.
- Immunodeficiency 104, severe combined (IMD104) MIM:608971
- Multiple sclerosis 3 (MS3) MIM:612595
Disease | GeneticClinVar
64 pathogenic / likely-pathogenic of 604 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Immunodeficiency 104
- Severe combined immunodeficiency disease
- Multiple sclerosis, susceptibility to, 3
- Histiocytic medullary reticulosis
- IL7R-related disorder
ReferencesPubMed · IEDB
Publications for IL7R from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
3 publications
- IL-7 receptor blockade inhibits IL-17-producing γδ cells and suppresses melanoma development.
2014 · Inflammation · RCR 0.5 · 18 citations - Combining anti-IL-7Rα antibodies with autoantigen-specific immunotherapy enhances non-specific cytokine production but fails to prevent Type 1 Diabetes.
2019 · PLoS One · RCR 0.1 · 3 citations - Neutralizing the IL-7Rα limits injury in experimental ANCA-associated glomerulonephritis.
2025 · Nephrol Dial Transplant · 1 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.04
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.29
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- B cell homeostasis
- B cell proliferation
- cell morphogenesis
- cell surface receptor signaling pathway
- cellular homeostasis
- defense response to Gram-positive bacterium
- gene expression
- hemopoiesis
- immune response
- interleukin-7-mediated signaling pathway
- lymph node development
- negative regulation of T cell apoptotic process
- negative regulation of T cell mediated cytotoxicity
- positive regulation of cell population proliferation
- positive regulation of gene expression
- positive regulation of receptor signaling pathway via JAK-STAT
- positive regulation of receptor signaling pathway via STAT
- positive regulation of T cell differentiation in thymus
- regulation of cell size
- regulation of DNA recombination
- signal transduction
- T cell differentiation in thymus
- T cell homeostasis
- T cell mediated cytotoxicity
Molecular functions
- antigen binding
- cytokine receptor activity
- interleukin-7 receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Short hematopoietin receptor, family 1, conserved site
- Fibronectin type III
- Immunoglobulin-like fold
- Fibronectin type III superfamily
- Fibronectin type III domain
- IL-7Ralpha, fibronectin type III domain
- Fibronectin type III domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IL7R in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IL7R as an antibody target. Whether an autoantibody or antibody against IL7R could matter depends on whether native IL7R is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IL7R is annotated at the cell surface, where native IL7R is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IL7R as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...